Where to from here?, page-3

Hey Bourbasted
So the base technology is 1) a water soluble chemical that chelates metal ions in such a way that the entire complex coats solid surfaces, 2) other molecules which can interact with that coating and thus be adhered (e.g.  antibodies in immunoassay format), 3) creates an electron dense coating for battery terminals (my guess here) which facilitates energy transfer.
Results so far:

• No potential coating applications outside of biotech (except battery which so far has not been explored by an outside company?). There would seem to be something here for industrial paints or other adhesion technologies.
• Failure to reach any significant commercialization in biotech – EVEN WHEN THEY OWNED DIASOURCE!
• Failure to commercialize on better battery tech in an era when Tesla just announced a 200 kWh 600 mile range 250 MPH electric supercar.
• There now have been multiple management changes and organizational changes with no significant commercialization.
• Capital has infused life into Anteo again and again with no significant commercialization.

So an important question is: What has stayed the same through all these iterations and mis-steps?  Many opportunities have been presented over the years.  There must been some inherent problem at Anteo which is invisible to the outside investor.  If it’s not the tech, then what is it?